Skip to content
Sunday, September 8, 2024
Wall Street Insider
Deliver critical advise to busy investors
Search
Search
News
About Us
Services
Institutional Research
Portfolio Analysis
#1 Stock Pick
Subscriptions
Contact Us
CLIENT LOGIN
Home
News
Amgen ‘very encouraged’ by preliminary data from weight-loss-drug trial, as stock jumps
News
Amgen ‘very encouraged’ by preliminary data from weight-loss-drug trial, as stock jumps
May 3, 2024
Arthur Bleemer
Shares of Amgen Inc. rallied in the extended session Thursday after the drug maker posted adjusted earnings above expectations and executives said they are “very encouraged” by preliminary data from a trial of an injectable weight-loss drug.
Read more from source
Post navigation
DraftKings posts surge in revenue, hikes full-year sales guidance
Fortinet’s stock falls 8% after cybersecurity company’s quarterly billings drop